WO2003016544A1 - Procede d'elaboration d'acide 1,4-dihydroxy-2-naphtoique - Google Patents

Procede d'elaboration d'acide 1,4-dihydroxy-2-naphtoique Download PDF

Info

Publication number: WO2003016544A1
Authority: WO; WIPO (PCT)
Prior art keywords: dihydroxy; naphthoic acid; producing; composition; unpleasantness
Prior art date: 2001-08-10

Application number

PCT/JP2002/008010

Other languages

English (en)

French (fr)

Inventor

Yoshiro Sato

Seiya Makino

Nobuo Yoda

Kakuhei Isawa

Tomonori Kamiyama

Kenichi Hojyo

Mizue Saito

Naoki Taketomo

Keisuke Furuichi

Shuji Ikegami

Original Assignee

Meiji Dairies Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-10

Filing date

2002-08-06

Publication date

2003-02-27

2002-08-06 Application filed by Meiji Dairies Corporation filed Critical Meiji Dairies Corporation

2002-08-06 Priority to AU2002323899A priority Critical patent/AU2002323899B2/en

2002-08-06 Priority to NZ531192A priority patent/NZ531192A/en

2002-08-06 Priority to KR1020047001743A priority patent/KR100899615B1/ko

2002-08-06 Priority to JP2003521851A priority patent/JP4070721B2/ja

2002-08-06 Priority to CA2457055A priority patent/CA2457055C/en

2002-08-06 Priority to US10/486,421 priority patent/US7374915B2/en

2002-08-06 Priority to EP02755845A priority patent/EP1416052B8/en

2003-02-27 Publication of WO2003016544A1 publication Critical patent/WO2003016544A1/ja

2008-04-09 Priority to US12/100,075 priority patent/US7629155B2/en

2009-08-19 Priority to US12/543,814 priority patent/US7834061B2/en

2010-09-08 Priority to US12/877,471 priority patent/US8110607B2/en

Links

VOJUXHHACRXLTD-UHFFFAOYSA-N 1,4-dihydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC(O)=C21 VOJUXHHACRXLTD-UHFFFAOYSA-N 0.000 title abstract 6
239000000203 mixture Substances 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
208000029725 Metabolic bone disease Diseases 0.000 abstract 1
241000186429 Propionibacterium Species 0.000 abstract 1
230000003187 abdominal effect Effects 0.000 abstract 1
239000008267 milk Substances 0.000 abstract 1
210000004080 milk Anatomy 0.000 abstract 1
235000013336 milk Nutrition 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PCT/JP2002/008010 2001-08-10 2002-08-06 Procede d'elaboration d'acide 1,4-dihydroxy-2-naphtoique WO2003016544A1 (fr)

Priority Applications (10)

Application Number	Priority Date	Filing Date	Title
AU2002323899A AU2002323899B2 (en)	2001-08-10	2002-08-06	Process for producing 1,4-dihydroxy -2-naphthoic acid
NZ531192A NZ531192A (en)	2001-08-10	2002-08-06	Process for producing 1,4-dihydroxy-2-naphthoic acid and compositions made therefrom for regulating intestinal function
KR1020047001743A KR100899615B1 (ko)	2001-08-10	2002-08-06	1,4-디히드록시-2-나프토산의 제조방법
JP2003521851A JP4070721B2 (ja)	2001-08-10	2002-08-06	１，４−ジヒドロキシ−２−ナフトエ酸の製造法
CA2457055A CA2457055C (en)	2001-08-10	2002-08-06	Process for producing 1,4-dihydroxy-2-naphthoic acid
US10/486,421 US7374915B2 (en)	2001-08-10	2002-08-06	Process for producing 1,4-dihydroxy-2-naphthoic acid
EP02755845A EP1416052B8 (en)	2001-08-10	2002-08-06	Process for producing 1,4-dihydroxy-2-naphthoic acid
US12/100,075 US7629155B2 (en)	2001-08-10	2008-04-09	Process for producing 1,4-dihydroxy-2-naphthoic acid
US12/543,814 US7834061B2 (en)	2001-08-10	2009-08-19	Process for producing 1,4-dihydroxy-2-naphthoic acid
US12/877,471 US8110607B2 (en)	2001-08-10	2010-09-08	Process for producing 1,4-dihydroxy-2-naphthoic acid

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2001-244475		2001-08-10
JP2001244475		2001-08-10

Related Child Applications (2)

Application Number	Title	Priority Date	Filing Date
US10486421 A-371-Of-International		2002-08-06
US12/100,075 Division US7629155B2 (en)	2001-08-10	2008-04-09	Process for producing 1,4-dihydroxy-2-naphthoic acid

Publications (1)

Publication Number	Publication Date
WO2003016544A1 true WO2003016544A1 (fr)	2003-02-27

Family

ID=19074394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/JP2002/008010 WO2003016544A1 (fr)	2001-08-10	2002-08-06	Procede d'elaboration d'acide 1,4-dihydroxy-2-naphtoique

Country Status (9)

Country	Link
US (4)	US7374915B2 (ja)
EP (1)	EP1416052B8 (ja)
JP (1)	JP4070721B2 (ja)
KR (1)	KR100899615B1 (ja)
CN (2)	CN1820741A (ja)
AU (1)	AU2002323899B2 (ja)
CA (1)	CA2457055C (ja)
NZ (1)	NZ531192A (ja)
WO (1)	WO2003016544A1 (ja)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004085364A1 (ja) *	2003-03-26	2004-10-07	Meiji Dairies Corporation	１,４−ジヒドロキシ−２−ナフトエ酸の安定化方法
WO2005033323A1 (ja) *	2003-10-01	2005-04-14	Meiji Dairies Corporation	１，４−ジヒドロキシ−２−ナフトエ酸の製造法
WO2005072718A1 (ja) *	2004-01-28	2005-08-11	Kurume University	乳清発酵物を含有する医薬組成物
JP2005225794A (ja) *	2004-02-12	2005-08-25	Meiji Milk Prod Co Ltd	１，４−ジヒドロキシ−２−ナフトエ酸の安定化剤
WO2005099725A1 (ja) *	2004-04-13	2005-10-27	Meiji Dairies Corporation	炎症性腸疾患予防および／または治療剤
WO2006098447A1 (ja) *	2005-03-18	2006-09-21	Meiji Feed. Co., Ltd.	ビフィズス菌増殖促進成分を含有する飼料組成物及びその使用方法
WO2008088008A1 (ja)	2007-01-17	2008-07-24	Meiji Dairies Corporation	消化管機能異常症予防及び／又は治療剤
WO2009107380A1 (ja)	2008-02-29	2009-09-03	明治乳業株式会社	抗アレルギー剤
WO2014163031A1 (ja) *	2013-04-01	2014-10-09	株式会社明治	即効性の整腸剤
JP2016020339A (ja) *	2014-06-16	2016-02-04	学校法人産業医科大学	１，４−ジヒドロキシ−２−ナフトエ酸誘導体
JP2016164144A (ja) *	2010-05-21	2016-09-08	株式会社明治	皮膚状態の改善用組成物
KR20170022343A (ko)	2015-08-20	2017-03-02	김태웅	유산균 발효액, 플로랄 워터 및 생약 추출물을 기반으로 하는 피부 알레르기의 예방, 개선제

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002323899B2 (en)	2001-08-10	2007-06-28	Meiji Dairies Corporation	Process for producing 1,4-dihydroxy -2-naphthoic acid
US7241809B2 (en) *	2003-12-22	2007-07-10	Meiji Dairies Corporation	Method for treating inflammatory bowel diseases
US8093301B2 (en)	2005-08-26	2012-01-10	Meiji Co., Ltd.	Anti-allergic agent
KR20100087078A (ko) *	2007-11-27	2010-08-03	메이지뉴교오가부시기가이샤	유산균의 생잔성 향상제 및 생잔성 향상 방법, 및 식품 조성물
US8715644B2 (en) *	2008-05-26	2014-05-06	Compagnie Gervais Danone	Method for decreasing borborygmi by administering a bifidobacterium bacteria
FR2960001A1 (fr)	2010-05-12	2011-11-18	Univ Rennes	Vecteur recombinant pour la production et la secretion de sequences d'acides amines d'interet par les bacteries propioniques et ses applications
KR101342791B1 (ko)	2012-08-16	2013-12-19	주식회사 제이케이뉴트라	1,4-디히드록시-2-나프토산 생산능을 가지는 락토바실러스 카제이 ｌｐ1 균주 및 이의 이용
US11179427B2 (en)	2013-01-21	2021-11-23	Eth Zurich	Baby food composition comprising viable propionic acid-producing bacteria
EP2829274A1 (en)	2013-07-25	2015-01-28	Institut National De La Recherche Agronomique	Vectors for producing and secreting substance of interest by bacteria and applications thereof
WO2016183535A1 (en)	2015-05-14	2016-11-17	University Of Puerto Rico	Methods for restoring microbiota of newborns
WO2017117142A1 (en)	2015-12-28	2017-07-06	New York University	Device and method of restoring microbiota of newborns
KR102127108B1 (ko) *	2018-06-26	2020-06-26	고려대학교산학협력단	프로피오니바크테리움 후레우덴레이키, 이의 배양액 또는 이의 사균체를 유효성분으로 함유하는 골질환의 예방 또는 치료용 조성물

Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0898677A (ja) *	1994-04-26	1996-04-16	Meiji Milk Prod Co Ltd	ビフィズス菌増殖促進組成物
JPH0975095A (ja) *	1995-09-14	1997-03-25	Unitika Ltd	２，４−ジヒドロキシ−３−ナフトエ酸の製造方法
JPH1014589A (ja) *	1996-07-08	1998-01-20	Unitika Ltd	キャンディダ・リポリティカｈｎａ−１１０株及び２，６−ジヒドロキシ−３−ナフトエ酸の製造方法
JPH11228424A (ja) *	1998-02-06	1999-08-24	Kyodo Milk Ind Co Ltd	ビフィズス菌活性化物質とビフィズス菌活性増殖剤とそれを含有する食品
JP2000086525A (ja) *	1998-09-16	2000-03-28	Morishita Jintan Kk	カプセル配合打錠剤
JP2000256201A (ja) *	1999-03-02	2000-09-19	Meiji Milk Prod Co Ltd	ビフィズス菌によるオリゴ糖利用能改善剤
WO2001028547A1 (fr) *	1999-10-19	2001-04-26	Meiji Milk Products Co., Ltd	Produits alimentaires utiles dans la prevention et l'amelioration de maladies du metabolisme osseux et medicaments preventifs/therapeutiques pour des maladies du metabolisme osseux comprenant ces produits alimentaires
JP2001169749A (ja) *	1999-12-21	2001-06-26	Nitto Yakuhin Kogyo Kk	生菌組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5935910B2 (ja)	1981-02-02	1984-08-31	株式会社日本触媒	１，４−ジヒドロオキシ−２−ナフトエ酸の製造方法
JPS59186942A (ja)	1983-04-07	1984-10-23	Kawasaki Kasei Chem Ltd	粗製１，４−ジヒドロキシ−２−ナフトエ酸又はその塩の精製法
JPS60104037A (ja) *	1983-11-10	1985-06-08	Kawasaki Kasei Chem Ltd	１，４−ジヒドロキシ−２−ナフトエ酸の製造方法
AU2002323899B2 (en)	2001-08-10	2007-06-28	Meiji Dairies Corporation	Process for producing 1,4-dihydroxy -2-naphthoic acid

2002
- 2002-08-06 AU AU2002323899A patent/AU2002323899B2/en not_active Expired
- 2002-08-06 JP JP2003521851A patent/JP4070721B2/ja not_active Expired - Fee Related
- 2002-08-06 EP EP02755845A patent/EP1416052B8/en not_active Expired - Lifetime
- 2002-08-06 NZ NZ531192A patent/NZ531192A/en not_active IP Right Cessation
- 2002-08-06 CN CNA200510136146XA patent/CN1820741A/zh active Pending
- 2002-08-06 WO PCT/JP2002/008010 patent/WO2003016544A1/ja active IP Right Grant
- 2002-08-06 KR KR1020047001743A patent/KR100899615B1/ko not_active Expired - Lifetime
- 2002-08-06 US US10/486,421 patent/US7374915B2/en not_active Expired - Lifetime
- 2002-08-06 CA CA2457055A patent/CA2457055C/en not_active Expired - Lifetime
- 2002-08-06 CN CNB028155807A patent/CN1312285C/zh not_active Expired - Lifetime
2008
- 2008-04-09 US US12/100,075 patent/US7629155B2/en not_active Expired - Lifetime
2009
- 2009-08-19 US US12/543,814 patent/US7834061B2/en not_active Expired - Lifetime
2010
- 2010-09-08 US US12/877,471 patent/US8110607B2/en not_active Expired - Fee Related

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0898677A (ja) *	1994-04-26	1996-04-16	Meiji Milk Prod Co Ltd	ビフィズス菌増殖促進組成物
JPH0975095A (ja) *	1995-09-14	1997-03-25	Unitika Ltd	２，４−ジヒドロキシ−３−ナフトエ酸の製造方法
JPH1014589A (ja) *	1996-07-08	1998-01-20	Unitika Ltd	キャンディダ・リポリティカｈｎａ−１１０株及び２，６−ジヒドロキシ−３−ナフトエ酸の製造方法
JPH11228424A (ja) *	1998-02-06	1999-08-24	Kyodo Milk Ind Co Ltd	ビフィズス菌活性化物質とビフィズス菌活性増殖剤とそれを含有する食品
JP2000086525A (ja) *	1998-09-16	2000-03-28	Morishita Jintan Kk	カプセル配合打錠剤
JP2000256201A (ja) *	1999-03-02	2000-09-19	Meiji Milk Prod Co Ltd	ビフィズス菌によるオリゴ糖利用能改善剤
WO2001028547A1 (fr) *	1999-10-19	2001-04-26	Meiji Milk Products Co., Ltd	Produits alimentaires utiles dans la prevention et l'amelioration de maladies du metabolisme osseux et medicaments preventifs/therapeutiques pour des maladies du metabolisme osseux comprenant ces produits alimentaires
JP2001169749A (ja) *	1999-12-21	2001-06-26	Nitto Yakuhin Kogyo Kk	生菌組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KANEKO T. AND NODA K.: "Bifidogenic growth stimulator produces by propionic acid bacteria", JAPANESE JOURNAL OF DAIRY AND FOOD SCIENCE, vol. 45, no. 4, 1995, pages 83 - 91, XP002957396 *
MEGANATHAN R. ET AL.: "Menaquinone (vitamin K2) bio-synthesis: conversion of omicron-succinylbenzoic acid to 1,4-dihydroxy-2-naphthoic acid by mycobacterium phylei enzymes", J. BACTERIOL., vol. 140, no. 1, October 1979 (1979-10-01), pages 92 - 98, XP002957395 *

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010233577A (ja) *	2003-03-26	2010-10-21	Meiji Milk Prod Co Ltd	１，４−ジヒドロキシ−２−ナフトエ酸（ｄｈｎａ）を含有する飲食品の製造方法
CN1764627B (zh) *	2003-03-26	2016-05-25	株式会社明治	稳定1，4-二羟基-2-萘甲酸的方法
WO2004085364A1 (ja) *	2003-03-26	2004-10-07	Meiji Dairies Corporation	１,４−ジヒドロキシ−２−ナフトエ酸の安定化方法
US8277860B2 (en)	2003-03-26	2012-10-02	Meiji Co., Ltd.	Method of stabilizing 1,4-dihydroxy-2-naphthoic acid
KR101003344B1 (ko) *	2003-03-26	2010-12-23	메이지 데어리스 코포레이션	1,4-디히드록시-2-나프토산의 안정화 방법
JPWO2004085364A1 (ja) *	2003-03-26	2006-06-29	明治乳業株式会社	１，４−ジヒドロキシ−２−ナフトエ酸の安定化方法
JP4579158B2 (ja) *	2003-03-26	2010-11-10	明治乳業株式会社	１，４−ジヒドロキシ−２−ナフトエ酸の安定化方法
US8758842B2 (en)	2003-10-01	2014-06-24	Meiji Co., Ltd.	Process for producing 1,4-dihydroxy-2-naphthoic acid
EP2463376A3 (en) *	2003-10-01	2013-01-30	Meiji Co, Ltd.	Food and beverages for treating metabolic osteopathy
EP2463375A2 (en)	2003-10-01	2012-06-13	Meiji Co., Ltd.	Food and beverages for treating abdominal discomfort
WO2005033323A1 (ja) *	2003-10-01	2005-04-14	Meiji Dairies Corporation	１，４−ジヒドロキシ−２−ナフトエ酸の製造法
CN100422337C (zh) *	2003-10-01	2008-10-01	明治乳业株式会社	1,4-二羟基-2-萘甲酸的制造方法
US7507563B2 (en)	2003-10-01	2009-03-24	Meiji Dairies Corporation	Process for producing 1, 4-dihydroxy-2-naphthoic acid
EP2463376A2 (en)	2003-10-01	2012-06-13	Meiji Co, Ltd.	Food and beverages for treating metabolic osteopathy
KR101116244B1 (ko) *	2003-10-01	2012-03-09	가부시키가이샤 메이지	1,4-디히드록시-2-나프토산의 제조법
JPWO2005033323A1 (ja) *	2003-10-01	2007-11-15	明治乳業株式会社	１，４−ジヒドロキシ−２−ナフトエ酸の製造法
EP2463375A3 (en) *	2003-10-01	2013-01-30	Meiji Co., Ltd.	Food and beverages for treating abdominal discomfort
JP4613132B2 (ja) *	2003-10-01	2011-01-12	明治乳業株式会社	１，４−ジヒドロキシ−２−ナフトエ酸の製造法
WO2005072718A1 (ja) *	2004-01-28	2005-08-11	Kurume University	乳清発酵物を含有する医薬組成物
JP4507065B2 (ja) *	2004-02-12	2010-07-21	明治乳業株式会社	１，４−ジヒドロキシ−２−ナフトエ酸の安定化剤
JP2005225794A (ja) *	2004-02-12	2005-08-25	Meiji Milk Prod Co Ltd	１，４−ジヒドロキシ−２−ナフトエ酸の安定化剤
WO2005099725A1 (ja) *	2004-04-13	2005-10-27	Meiji Dairies Corporation	炎症性腸疾患予防および／または治療剤
US8025911B2 (en)	2004-04-13	2011-09-27	Meiji Dairies Corporation	Preventive and/or remedy for inflammatory bowel diseases
JPWO2005099725A1 (ja) *	2004-04-13	2008-03-06	明治乳業株式会社	炎症性腸疾患予防および／または治療剤
US8241684B2 (en)	2004-04-13	2012-08-14	Meiji Co., Ltd.	Preventive and/or therapeutic agent for inflammatory bowel diseases
JP2006254841A (ja) *	2005-03-18	2006-09-28	Meiji Shiryo Kk	ビフィズス菌増殖促進成分を含有する飼料組成物とその使用方法
WO2006098447A1 (ja) *	2005-03-18	2006-09-21	Meiji Feed. Co., Ltd.	ビフィズス菌増殖促進成分を含有する飼料組成物及びその使用方法
WO2008088008A1 (ja)	2007-01-17	2008-07-24	Meiji Dairies Corporation	消化管機能異常症予防及び／又は治療剤
US9675647B2 (en)	2007-01-17	2017-06-13	Meiji Co., Ltd.	Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
WO2009107380A1 (ja)	2008-02-29	2009-09-03	明治乳業株式会社	抗アレルギー剤
JP2016164144A (ja) *	2010-05-21	2016-09-08	株式会社明治	皮膚状態の改善用組成物
WO2014163031A1 (ja) *	2013-04-01	2014-10-09	株式会社明治	即効性の整腸剤
JPWO2014163031A1 (ja) *	2013-04-01	2017-02-16	株式会社明治	即効性の整腸剤
JP2016020339A (ja) *	2014-06-16	2016-02-04	学校法人産業医科大学	１，４−ジヒドロキシ−２−ナフトエ酸誘導体
JP2020010703A (ja) *	2014-06-16	2020-01-23	学校法人産業医科大学	１，４−ジヒドロキシ−２−ナフトエ酸誘導体
KR20170022343A (ko)	2015-08-20	2017-03-02	김태웅	유산균 발효액, 플로랄 워터 및 생약 추출물을 기반으로 하는 피부 알레르기의 예방, 개선제

Also Published As

Publication number	Publication date
US7374915B2 (en)	2008-05-20
KR100899615B1 (ko)	2009-05-27
JP4070721B2 (ja)	2008-04-02
NZ531192A (en)	2005-07-29
CA2457055A1 (en)	2003-02-27
EP1416052B1 (en)	2012-09-12
KR20040032886A (ko)	2004-04-17
AU2002323899B9 (en)	2003-03-03
EP1416052B8 (en)	2013-01-09
JPWO2003016544A1 (ja)	2004-12-02
US20110009491A1 (en)	2011-01-13
US7834061B2 (en)	2010-11-16
US7629155B2 (en)	2009-12-08
CN1820741A (zh)	2006-08-23
US20040241815A1 (en)	2004-12-02
CA2457055C (en)	2013-10-08
CN1312285C (zh)	2007-04-25
EP1416052A4 (en)	2005-10-12
EP1416052A1 (en)	2004-05-06
US8110607B2 (en)	2012-02-07
US20090312425A1 (en)	2009-12-17
CN1539019A (zh)	2004-10-20
US20080194688A1 (en)	2008-08-14
AU2002323899B2 (en)	2007-06-28

Legal Events

Date	Code	Title	Description
2003-02-27	AK	Designated states	Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW
2003-02-27	AL	Designated countries for regional patents	Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
2003-03-27	DFPE	Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
2003-04-23	121	Ep: the epo has been informed by wipo that ep was designated in this application
2004-01-29	WWE	Wipo information: entry into national phase	Ref document number: 2003521851 Country of ref document: JP
2004-02-04	WWE	Wipo information: entry into national phase	Ref document number: 1020047001743 Country of ref document: KR
2004-02-09	WWE	Wipo information: entry into national phase	Ref document number: 20028155807 Country of ref document: CN Ref document number: 2002755845 Country of ref document: EP
2004-02-10	WWE	Wipo information: entry into national phase	Ref document number: 2002323899 Country of ref document: AU Ref document number: 2457055 Country of ref document: CA
2004-02-17	WWE	Wipo information: entry into national phase	Ref document number: 531192 Country of ref document: NZ
2004-05-06	WWP	Wipo information: published in national office	Ref document number: 2002755845 Country of ref document: EP
2004-06-24	REG	Reference to national code	Ref country code: DE Ref legal event code: 8642
2004-07-13	WWE	Wipo information: entry into national phase	Ref document number: 10486421 Country of ref document: US
2005-07-29	WWP	Wipo information: published in national office	Ref document number: 531192 Country of ref document: NZ
2005-11-10	WWG	Wipo information: grant in national office	Ref document number: 531192 Country of ref document: NZ
2007-10-11	WWG	Wipo information: grant in national office	Ref document number: 2002323899 Country of ref document: AU

Publication	Publication Date	Title
WO2003016544A1 (fr)	2003-02-27	Procede d'elaboration d'acide 1,4-dihydroxy-2-naphtoique
EP1283054A4 (en)	2006-04-12	MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
KR101467316B1 (ko)	2014-12-01	발효 포공영 추출물-함유 복합 생약재 추출물을 유효성분으로 함유하는 구강세정용 조성물
EP2360139A3 (en)	2012-04-11	Ferric organic compounds, uses thereof and methods of making same
AU2728900A (en)	2000-08-07	Multi-purpose acid compositions
NZ272610A (en)	1997-08-22	The manufacture of dispersible tablets containing fluoxetine by direct compression
CN101040936B (zh)	2011-10-19	防治鱼类寄生虫病的复方中草药制剂
WO2002083879A3 (en)	2002-12-12	Immunotherapy based on dendritic cells
WO2003032907A3 (en)	2004-02-19	High-concentration protein formulations and method of manufacture
ATE342725T1 (de)	2006-11-15	Verwendung eines mittels zur verbesserung des knochenmetabolismus
WO2003059246A3 (en)	2003-10-16	Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
EP1297837A4 (en)	2005-12-07	MEDICAMENTS FOR ALLERGIC DISEASES AND METHOD FOR THE MANUFACTURE OF THE SAME
CN1205869C (zh)	2005-06-15	一种降低砖茶含氟量的加工制作方法
EP1550443A4 (en)	2009-04-01	COMPOSITION AGAINST STRESS-BASED DISEASES
WO2006047470A3 (en)	2006-06-22	Compositions containing malva sylvestris extract and use thereof on skin or mucosal tissues
JP2004154675A (ja)	2004-06-03	構造化濃縮深層水を用いた環境浄化剤
WO2004093867A3 (en)	2004-12-02	Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
EP1735005A4 (en)	2009-11-11	METHOD OF CAPTIVATING ORAL-INFLUENCED MATERIALS FOR CHANGING THE DENTAL LOCATION; THE EFFORT OR THE STABILITY "
WO2003101399A3 (en)	2004-07-08	Novel bacterium for treatment of disease
EP1491192A4 (en)	2007-08-15	COMPOSITIONS STRENGTHENING BIOLOGICAL ACTIVITY THAT CONTAIN AN ISOFLAVONE AGLYCONE FROM SOYBEAN GERMS
WO2004093827A3 (en)	2005-03-10	Phenolic acid salts of gabapentin in solid dosage forms and methods of use
CN108670920A (zh)	2018-10-19	一种增白的牙膏
CN1330893A (zh)	2002-01-16	鱼腥草饮料
CN108542799A (zh)	2018-09-18	一种含维生素c的牙膏
Curzon	1988	Effects of a combination of strontium and fluoride on dental caries in the rat